Skip to main content

Taysha Gene Therapies, Inc.

TSHA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001806310

In the last 90 days, Taysha Gene Therapies, Inc. insiders filed 0 open-market purchases and 1 sale; 208 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.

13F holders, Q2 2021

Institutional positions in Taysha Gene Therapies, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
49
+3 vs. Q1 2021
Shares held
18.3M
+666.9K (+3.8%) vs. Q1 2021
Total value
$388.6M
+$30.0M (+8.4%) vs. Q1 2021
New holders
11
26 more added
Sold out
8
5 more reduced

Compare with Q1 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TSHA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2021: 49 institutions
Q1 2021: 46 institutionsQ2 2021: 49 institutionsQ3 2021: 48 institutionsQ4 2021: 65 institutionsQ1 2022: 71 institutionsQ2 2022: 59 institutionsQ3 2022: 54 institutionsQ4 2022: 52 institutionsQ1 2023: 44 institutionsQ2 2023: 39 institutionsQ3 2023: 63 institutionsQ4 2023: 87 institutionsQ1 2024: 109 institutionsQ2 2024: 107 institutionsQ3 2024: 119 institutionsQ4 2024: 131 institutionsQ1 2025: 127 institutionsQ2 2025: 150 institutionsQ3 2025: 155 institutionsQ4 2025: 195 institutionsQ1 2026: 191 institutionsQ2 2026: 208 institutions
Value heldQ2 2021: $388.6M
Q1 2021: $358.5MQ2 2021: $388.6MQ3 2021: $361.9MQ4 2021: $215.6MQ1 2022: $110.9MQ2 2022: $54.7MQ3 2022: $27.0MQ4 2022: $43.8MQ1 2023: $13.3MQ2 2023: $9.05MQ3 2023: $410.6MQ4 2023: $230.3MQ1 2024: $402.2MQ2 2024: $354.3MQ3 2024: $315.5MQ4 2024: $289.8MQ1 2025: $232.0MQ2 2025: $595.4MQ3 2025: $865.6MQ4 2025: $1.48BQ1 2026: $1.18BQ2 2026: $2.03B
Institutions holding TSHA and their total value by quarter
QuarterHoldersValue
Q2 2026208$2.03B
Q1 2026191$1.18B
Q4 2025195$1.48B
Q3 2025155$865.6M
Q2 2025150$595.4M
Q1 2025127$232.0M
Q4 2024131$289.8M
Q3 2024119$315.5M
Q2 2024107$354.3M
Q1 2024109$402.2M
Q4 202387$230.3M
Q3 202363$410.6M
Q2 202339$9.05M
Q1 202344$13.3M
Q4 202252$43.8M
Q3 202254$27.0M
Q2 202259$54.7M
Q1 202271$110.9M
Q4 202165$215.6M
Q3 202148$361.9M
Q2 202149$388.6M
Q1 202146$358.5M

Institutions, Q2 2021

Shares, value and share of portfolio for each institution holding Taysha Gene Therapies, Inc.; share changes are against Q1 2021.

Institutions holding TSHA in Q2 2021
InstitutionSharesValue% of portfolioChange in sharesAction
FMR LLC5,687,616$120.6M0.01%+23,401+0.4%Added
BlackRock Inc.2,966,771$62.9M0.00%+705,526+31.2%Added
University of Texas/Texas Am Investment Managment Co1,391,190$29.5M22.62%−787,810−36.2%Reduced
Franklin Resources Inc1,305,846$27.7M0.01%+186,677+16.7%Added
Artal Group S.A.1,040,882$22.1M0.50%00.0%Unchanged
Sands Capital Management, LLC724,873$15.4M0.03%00.0%Unchanged
TimesSquare Capital Management, LLC683,400$14.5M0.12%+286,200+72.1%Added
Alphabet Inc.640,882$13.6M0.28%00.0%Unchanged
Vanguard Group Inc628,644$13.3M0.00%+168,396+36.6%Added
Tybourne Capital Management (HK) Ltd500,000$10.6M0.22%00.0%Unchanged
Nantahala Capital Management, LLC432,072$9.16M0.51%+395,116+1,069.2%Added
Perceptive Advisors LLC320,440$6.79M0.09%−150,000−31.9%Reduced
Octagon Capital Advisors LP320,440$6.79M1.41%00.0%Unchanged
State Street Corp318,619$6.75M0.00%+196,478+160.9%Added
Geode Capital Management, LLC263,442$5.58M0.00%+110,980+72.8%Added
JPMorgan Chase & Co213,646$4.53M0.00%+187,423+714.7%Added
Northern Trust Corp198,859$4.22M0.00%+101,935+105.2%Added
Charles Schwab Investment Management Inc87,030$1.85M0.00%+28,787+49.4%Added
Nuveen Asset Management, LLC80,422$1.71M0.00%+62,821+356.9%Added
Bank of New York Mellon Corp56,672$1.20M0.00%+29,740+110.4%Added
Granite Point Capital Management, L.P.50,000$1.06M0.31%+50,000New
Gilder Gagnon Howe & Co LLC37,640$798.0K0.00%−184−0.5%Reduced
Swiss National Bank37,500$795.0K0.00%+37,500New
Morgan Stanley36,110$766.0K0.00%+13,149+57.3%Added
Pura Vida Investments, LLC33,822$717.0K0.05%+33,822New
California State Teachers Retirement System30,712$651.0K0.00%+17,584+133.9%Added
Millennium Management LLC30,165$639.0K0.00%+9,040+42.8%Added
State of Wisconsin Investment Board28,800$611.0K0.00%+28,800New
Bank of America Corp24,379$517.0K0.00%+9,524+64.1%Added
New York State Common Retirement Fund19,174$406.0K0.00%+10,374+117.9%Added
Rhumbline Advisers18,671$396.0K0.00%+18,671New
Davenport & Co LLC13,750$292.0K0.00%−6,400−31.8%Reduced
Deutsche Bank AG13,522$286.0K0.00%+7,670+131.1%Added
Credit Suisse AG13,389$283.0K0.00%+13,389New
Manufacturers Life Insurance Company, The12,965$275.0K0.00%+12,965New
American International Group, Inc.12,474$264.0K0.00%+7,415+146.6%Added
D. E. Shaw & Co., Inc.11,448$243.0K0.00%+11,448New
MetLife Investment Management9,509$201.6K0.00%+9,509New
Virtus ETF Advisers LLC8,697$184.0K0.08%+8,697New
Metropolitan Life Insurance Co7,280$154.3K0.00%+7,280New
UBS Group AG5,300$112.0K0.00%−30,911−85.4%Reduced
Legal & General Group Plc3,749$80.0K0.00%+2,835+310.2%Added
Ameritas Investment Partners, Inc.1,745$37.0K0.00%+1,018+140.0%Added
Royal Bank of Canada1,532$32.0K0.00%+657+75.1%Added
Citigroup Inc1,371$29.0K0.00%+795+138.0%Added
Captrust Financial Advisors1,021$22.0K0.00%+60+6.2%Added
Tower Research Capital LLC (TRC)976$21.0K0.00%+350+55.9%Added
Brewin Dolphin Ltd250$5.30K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.241$5.00K0.00%00.0%Unchanged
Casdin Capital, LLC0$00.00%−820,440−100.0%Sold out
VR Adviser, LLC0$00.00%−120,649−100.0%Sold out
ArrowMark Colorado Holdings LLC0$00.00%−115,723−100.0%Sold out
Wells Fargo & Company0$00.00%−57,412−100.0%Sold out
Alyeska Investment Group, L.P.0$00.00%−25,000−100.0%Sold out
HRT Financial LP0$00.00%−12,239−100.0%Sold out
STRS Ohio0$00.00%−2,100−100.0%Sold out
Bank of Montreal0$00.00%−268−100.0%Sold out